newsfilter
← Latest News
PR Newswire·

Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.

Combination Strengthens Indivior's Addiction Treatment and Science Portfolio RICHMOND, Va., March 2, 2023 /PRNewswire/ -- Indivior PLC (LSE: INDV) ("Indivior" or the "Company") today announced that it